In breast cancer cell lines, the blockade of EGFR by antibodies or small-molecule inhibitors induces nuclear translocation of FOXO3a and promotes the expression of BNIP3L gene, which consequently results in apoptotic death of breast cancer cells [143]. Here, BNIP3L is linked to breast carcinoma.